Himcospaz (capsule)

Total no. of papers:5 - Clinical Papers:4, Experimental Papers:1
(Research papers based on Indications)

Spasmodic pain in uterus

1. Antispasmodics – A new perspective
   Kala Suhas Kulkarni, Medical Advisor, R&D Center, The Himalaya Drug Company, Makali, Bengaluru, India, JAMA India (2001): (4), 8, 119-121.

Abdominal colic

2. Evaluation of efficacy and safety of Himcospaz drops in infantile abdominal colic
   Dr. Shakuntala Prabhu1 and Dr. S.A. Kolhapure*2, M.D.,
   1 Associate Professor and Unit Head, Bai Jerbai Wadia Hospital for Children, Parel, Mumbai-400 012, India.
   2 Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Makali, Bengaluru – 562 123, India. The Antiseptic 2004; 101(8), 312-317
   
   
3. Evaluation of the efficacy and safety of Himcospaz in non-specific abdominal colic
   Tiwari, S.K. and Sailaja Vani, B., Department of Kayachikitsa, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, Capsule (2003): XLIII, 2 - July/September.



4. Clinical evaluation of the efficacy and safety of SJ-200 in the management of spasmodic visceral pain
   Singh, V.K. and Singh, R.H., Department of Kayachikitsa, S.S. Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, Indian Journal of Clinical Practice (2002): (13), 3, 49-51.